Levetiracetam and Partial Seizure Subtypes: Pooled Data from Three Randomized, Placebo-controlled Trials

Epilepsia

Volumn 44, Issue 12, 2003, Pages 1585-1587

  Leppik, Ilo E ^a,e   Biton, Victor ^b   Sander, Josemir W A ^c   Wieser, Heinz Gregor ^d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Arkansas Epilepsy Program   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e MINCEP Epilepsy Care   (United States)

Author keywords

Partial seizures; Secondary generalized seizures; Seizure subtypes

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; PRIMIDONE; VALPROIC ACID; VIGABATRIN;

ADULT; ARTICLE; CLINICAL TRIAL; COMPLEX PARTIAL SEIZURE; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; FOCAL EPILEPSY; GRAND MAL SEIZURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STATISTICAL SIGNIFICANCE;

EID: 0347994963     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0013-9580.2003.00403.x     Document Type: Article

References (10)

1. Klitgaard H, Matagne A, Gobert J, et al. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. Eur J Pharmacol 1998;353:191-206.
2. Löscher W, Hönack D. Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats. Eur J Pharmacol 1993;232:147-58.
3. Margineanu D-G, Klitgaard H. Levetiracetam: mechanisms of action. In: Levy RH, Mattson BS, Perucca E, et al., eds. Antiepileptic drugs. 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2002:419-27.
4. Patsalos PN. Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacol Ther 2000;85:77-85.
5. Ben-Menachem E, Falter U. Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial onset seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. Epilepsia 2000;41:1276-83.
6. Cereghino JJ, Biton V, Abou-Khalil B, et al. Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial. Neurology 2000;55:236-42.
7. Shorvon SD, Löwenthal A, Janz D, et al. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as addon therapy in patients with refractory partial seizures. Epilepsia 2000;41:1179-86.
8. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-99.
9. Agresti A. Analysis of ordinal categorical data. New York: John Wiley & Sons, 1984: (Wiley series in probability and mathematical statistics) 120-37.
10. Shorvon SD, van Rijckevorsel K. Levetiracetam. a pyrrolidone recently licensed as an antiepileptic drug. J Neurol Neurosurg Psychiatry 2002;72:426-9.